Table 3.
Activity of ebselen on targets from pathogen.
| Target | IC50(µM) | Covalent | Reference |
|---|---|---|---|
| Cryptosporidium parvum glucose-6-phosphate isomerase | 8.33 | Yes | Eltahan et al.46 |
| Tumor marker endothelial 8 and protective antigen interaction | 1.7 | Yes | Cryan et al.37 |
| Trypanosoma brucei hexokinase 1 | 0.05 | Yes | Gordhan et al.47 |
| Escherichia coli thioredoxin reductase | 0.52 (Ki) | Yes | Lu et al.48 |
| C-terminal domain of HIV-1 capsid | 0.047 | Yes | Thenin-Houssier et al.39 |
| Bacillus anthracis thioredoxin reductase | 1 | ND | Gustafsson et al.49 |
| Clostridium difficile cysteine protease domain | 0.0069 | Yes | Bender et al.50 |
| New Delhi metallo-β-lactamase | 0.38 | Yes | Chiou et al.51 |
| Mycobacterium tuberculosis antigen 85 | 0.063 | Yes | Favrot et al.52 |
| Hepatitis C Virus NS3 Helicase-Nucleic Acid interaction | 1.1/0.9 | Yes | Mukherjee et al.53 |
| Cryptosporidium parvum Inosine 5′-monophosphate dehydrogenase | 0.71 | Yes | Sarwono et al.54 |
| Pseudomonas aeruginosa Diguanylate Cyclases | 5 | Yes | Lieberman et al.55 |